scholarly journals Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update

2017 ◽  
Vol 151 (1) ◽  
pp. 33-42 ◽  
Author(s):  
Sarah A. Lamb ◽  
Yazid N. Al Hamarneh ◽  
Sherilyn K. D. Houle ◽  
Alexander A. Leung ◽  
Ross T. Tsuyuki
2020 ◽  
Vol 23 (2) ◽  
pp. 205-209
Author(s):  
Amanda Giffin ◽  
Kenneth M. Madden ◽  
David B. Hogan

In 2017, Hypertension Canada removed advanced age and frailty as considerations for caution when deciding on intensive therapy in their guidelines for the diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Dementia is not mentioned. In this commentary, we review why advanced age and frailty were removed, and examine what is currently known about the relationship between hypertension and both incident and prevalent dementia. We make the case that the presence of frailty (especially when severe) and dementia should be considered when deciding on intensive therapy in future iterations of Hypertension Canada guidelines.


2018 ◽  
Vol 34 (5) ◽  
pp. 506-525 ◽  
Author(s):  
Kara A. Nerenberg ◽  
Kelly B. Zarnke ◽  
Alexander A. Leung ◽  
Kaberi Dasgupta ◽  
Sonia Butalia ◽  
...  

2017 ◽  
Vol 33 (5) ◽  
pp. 557-576 ◽  
Author(s):  
Alexander A. Leung ◽  
Stella S. Daskalopoulou ◽  
Kaberi Dasgupta ◽  
Kerry McBrien ◽  
Sonia Butalia ◽  
...  

1991 ◽  
Vol 5 (3) ◽  
pp. 208-214 ◽  
Author(s):  
Sheila A. Corrigan ◽  
James M. Raczynski ◽  
Charles Swencionis ◽  
Stephanie G. Jennings

Sign in / Sign up

Export Citation Format

Share Document